KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Capital Employed (2016 - 2025)

Pfizer (PFE) has disclosed Return on Capital Employed for 14 consecutive years, with 0.38% as the latest value for Q4 2024.

  • On a quarterly basis, Return on Capital Employed fell 21.0% to 0.38% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.38%, a 21.0% decrease, with the full-year FY2024 number at 0.21%, down 28.0% from a year prior.
  • Return on Capital Employed was 0.38% for Q4 2024 at Pfizer, down from 0.16% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 1.52% in Q2 2023 to a low of 0.38% in Q4 2024.
  • A 3-year average of 0.14% and a median of 0.1% in 2023 define the central range for Return on Capital Employed.
  • Biggest YoY gain for Return on Capital Employed was -14bps in 2024; the steepest drop was -21bps in 2024.
  • Pfizer's Return on Capital Employed stood at 0.16% in 2021, then plummeted by -203bps to 0.17% in 2023, then crashed by -125bps to 0.38% in 2024.
  • Per Business Quant, the three most recent readings for PFE's Return on Capital Employed are 0.38% (Q4 2024), 0.16% (Q3 2024), and 0.17% (Q4 2023).